Dr. Coric has more than 15 years of drug discovery and clinical development experience at Yale School of Medicine and Bristol-Myers Squibb.
Biohaven Pharmaceuticals is a biopharmaceutical company that develops product candidates targeting neurological diseases and rare disorders in the United States.
Veradermics, Inc. is a medical dermatology company advancing first-in-class therapeutics that address real-world patient needs in under-innovated dermatology markets.